Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportOncology: Basic, Translational & Therapy

Comparison of 18F-FDG kinetics between oral uptake and venous injection

Kaixiu Zhang, Xuedong Luo, Chunlei Han and Xuemei Wang
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1274;
Kaixiu Zhang
2Nuclear Medicine, Inner Mongolia Medical University Hospital, Hohhot, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xuedong Luo
3Health Centre of Women and Children of Inner Mongolia Autonomous Region, Hohhot, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chunlei Han
1Turku PET Centre, Turku Trk, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xuemei Wang
2Nuclear Medicine, Inner Mongolia Medical University Hospital, Hohhot, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1274

Objectives FDG-PET has been widely applied in oncology. Usually, FDG is administrated intravenously. However, venous access is not always available. Oral administration is thus an alternative consideration. This study was designated to investigate kinetics of FDG after oral uptake to optimize imaging protocol.

Methods 4 volunteers were enrolled. FDG was injected intravenously in one subject as a venous group (VG). In another three subjects, FDG was administrated orally, with 500 ml water, as an oral group (OG). Dosage of FDG was same for both groups, 0.1 mCu/kg. After administration of FDG, static scanning was acquired at 5, 20, 35, 50 and 70 min. Regions of interest (ROI) was drawn on mouth, esophagus, stomach, small intestine, colon, brain, lung, left ventricular cavity, left ventricular myocardium, liver and kidney. Mean activities in ROIs were taken in time series as a tissue-active curve. Image analysis was performed using Carimas (Turku PET Centre of Finland). Based on tissue-active curves from each organ, time reaching 90% of maximum was defined as maximal uptake time (MUT) for OG.

Results In VG, uptake of FDG in different organs was very fast, after 5-10 min, activity in brain, liver, lung and kidney reaches the plateau, except myocardium continued to take FDG. In OG, FDG was seen clearly to go dynamically through mouth, esophagus, stomach, small intestine and colon. After 5 min, radio activity starts to appear in liver, lung, kidney, heart and brain. MUT was 30, 43, 50 and 65 min for liver, lung, kidney and brain, respectively. Note that activity was still going up in brain at end of observation, implying that uptake of FDG in brain tissue does not reach maximum after 70 min.

Conclusions Oral FPG uptake is an alternative way for patients with difficult venous access. PET images should be acquired at around 60 min after oral FDG administration. For brain, a longer interval (>70min) is required.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 56, Issue supplement 3
May 1, 2015
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Comparison of 18F-FDG kinetics between oral uptake and venous injection
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Comparison of 18F-FDG kinetics between oral uptake and venous injection
Kaixiu Zhang, Xuedong Luo, Chunlei Han, Xuemei Wang
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1274;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Comparison of 18F-FDG kinetics between oral uptake and venous injection
Kaixiu Zhang, Xuedong Luo, Chunlei Han, Xuemei Wang
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1274;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Basic, Translational & Therapy

  • Recombinant human thyroid-stimulating hormone vs thyroid hormone withdrawal in 124I-PET/CT based 3D radiobiological dosimetry (3D-RD) for 131I therapy of metastatic differentiated thyroid cancer
  • Tumor volume, FDG uptake, and Tumor dose in correlation with treatment volume change after Y-90 radioembolization in patients with hepatocellular carcinoma
  • Ac-225-DOTATOC - an empiric dose finding for alpha particle emitter based radionuclide therapy of neuroendocrine tumors
Show more Oncology: Basic, Translational & Therapy

MTA I: Technical Advances & Quantification Posters

  • The Clinical implication of trimodality PET/CT-MR in head and neck tumor
  • SUVmax of Normal Tissues in Pediatric and Adult Patients on FDG PET/MR
Show more MTA I: Technical Advances & Quantification Posters

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire